Document is current

Any future updates will be listed below

Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma

Crossref DOI link: https://doi.org/10.1186/s40425-017-0229-2

Published Online: 2017-03-21

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark